NYSE:GMED
Globus Medical Inc.
Globus Medical Inc.'s revenue grew 16.7% in fiscal 2025 to $2.9B while operating margin rose to 16.3%. Free cash flow was $588.8M, 20.0% of revenue, and the diluted share count fell 0.6%.Summary generated from Globus Medical Inc.'s SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.9B
Revenue growth+16.7%
Revenue, 5-yr CAGR+30.1%
Gross margin67.4%
Operating margin16.3%
Net margin18.3%
ROICn/a
Return on equity12.3%
Debt / equityn/a
Free cash flow$588.8M
FCF margin20.0%
Share count change−0.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 958 | 1,023 | 1,568 | 2,519 | 2,939 |
| Operating income | 172 | 228 | 133 | 166 | 480 |
| Net income | 149 | 190 | 123 | 103 | 538 |
| Free cash flow | 219 | 104 | 165 | 405 | 589 |
Recent filings
- 4Insider transaction report
Sep 16, 2026 - 4Insider transaction report
Aug 19, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KDirector or officer change
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - DEF 14AProxy statement
Apr 24, 2026